Feature | Value |
M/F, n | 26/19 |
Mean age, years | 43 (range 22–67) |
Mean age at symptom onset, years | 35 (range 18–67) |
Mean disease duration, months | 99 (range 3–600) |
BASDAI | 4.4 (2.6–5.6)* |
BASMI | 2.5 (1–4)* |
BASFI | 3.0 (1.3–5.5)* |
HAQ | 0.625 (0.31–1.375)* |
VAS patient, cm | 5 (3.4–6.5)* |
VAS physician, mm | 4 (3.1–5.6)* |
Erythrocyte sedimentation rate, mm/h | 18 (7–34)* |
C-reactive protein, mg/l | 3 (1–11.25)* |
Treatment, n (%) | |
Corticosteroids | 17 (37.7) |
NSAID | 29 (62.2) |
DMARD | 12 (26.7) |
Anti-TNF drugs | 22 (48.9) |
*Median (25th–75th percentile). BASDAI, Bath ankylosing spondylitis disease activity index; BASFI, Bath ankylosing spondylitis functional index; BASMI, Bath ankylosing spondylitis metrology index; DMARD, disease-modifying antirheumatic drug; HAQ, health assessment questionnaire; NSAID, non-steroidal anti-inflammatory drug; SpA, spondyloarthropathy; TNF, tumour necrosis factor; VAS, visual analogue scale.